Overview
Updated 14 Jul 2026
Dan Toby Vogl, MD, is Associate Professor of Medicine (Hematology-Oncology), Hospital of the University of Pennsylvania. The public record shows 365 publications with 18,237 citations (h-index 50), centered on Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Protein Degradation and Inhibitors. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 13 companies, 4 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · Blood cancer journal
- Top research focus: Multiple Myeloma Research and Treatments
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 30 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 124.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
Sponsor: University of Pennsylvania
InvestigatorPhase 1TerminatedNCT04405167 - Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Sponsor: CellCentric Ltd.
InvestigatorPhase 1/PHASE2RecruitingNCT04068597 - Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
Sponsor: Abramson Cancer Center at Penn Medicine
InvestigatorActive, not recruitingNCT01985919
Industry payments
Updated 14 Jul 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Teva Pharmaceuticals USA, Inc.Program year20252 payments
- GENZYME CORPORATIONProgram year20252 payments
- Janssen Scientific Affairs, LLCProgram year20251 payment
NIH funding
Updated 14 Jul 2026
4 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
Congress activity
Updated 14 Jul 2026
63 congress contributions (2006–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Clinical activity of novel targeting of S100A9 with tasquinimod for relapsed and refractory multiple myeloma (RRMM).
ASCO Annual Meeting
ASCO2025Presenting author - Disease response at apheresis and association with long-term outcomes following CAR-T cells for relapsed/refractory multiple myeloma (RRMM).
ASCO Annual Meeting
ASCO2025Co-author - CCR5 blockade: A therapeutic approach to uncouple CART-BCMA expansion from CART-mediated immune toxicities.
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited worksby citation count (OpenAlex)
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Perelman Center for Advanced Medicine, 12th Floor South Pavilion, Office #12-176, 3400 Civic Center Boulevard, Philadelphia, PA 19104
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- Board certified in Internal Medicine
Medical Oncology, and Hematology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pennmedicine.org ↗ - Internal medicine residency
Columbia-Presbyterian Medical Center, New York
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pennmedicine.org ↗ - Hematology-Oncology fellowship
Hospital of the University of Pennsylvania, Philadelphia
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pennmedicine.org ↗
Editorial & leadership rolesjournal and society appointments
- Medical Director
Abramson Cancer Center Clinical Research Unit (oversees 140+ research nurses, coordinators, and biospecimen staff managing 300+ active cancer clinical trials)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Senior Scholar
Center for Clinical Epidemiology and Biostatistics (CCEB), University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cceb.med.upenn.edu ↗ - Member
Penn Myeloma Program, Amyloidosis Program, and Cellular Therapy and Transplant Program
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthtree.org ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lls.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- Video interview speaker profile
VJHemOnc (hematology/oncology video journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗ - Podcast guest
HealthTree/Myeloma Crowd Radio - "Tasquinimod As a New Myeloma Therapy with Dan Vogl" (with Yulia Nefedova, Wistar Institute)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthtree.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/dan-vogl-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Dan-Vogl
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/danvogl
Mentions by otherswhere others cite or feature them
- Other
lls.org/award-recipient/dan-vogl
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lls.org ↗ - Other
onclive.com/authors/dan-vogl-md-msce
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Other
vjhemonc.com/speaker/dan-vogl
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
- 1,422
- publications
- 179
- h-index
- 2
- trials
David Callans, MD
University of Pennsylvania
- 767
- publications
- 96
- h-index
- 7
- trials
Stephen Schuster, MD
University of Pennsylvania
- 804
- publications
- 77
- h-index
- 11
- trials
Kenneth Margulies, MD
University of Pennsylvania
- 605
- publications
- 89
- h-index
- 2
- trials